)
Extendicare (EXE) investor relations material
Extendicare Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q1 2026 results reflect strong execution of strategy, with organic growth in Home Healthcare, successful acquisitions including the $570 million CBI Home Health deal, and progress in long-term care redevelopment through joint ventures.
Adjusted EBITDA excluding out-of-period items rose 52.2% year-over-year to $44.2 million, with reported Adjusted EBITDA at $52.9 million, and net earnings surged 171% to $40.7 million.
Revenue increased 24.2% year-over-year to $465.2 million, driven by 32.7% Home Healthcare volume growth and acquisitions.
Issued $450 million in senior unsecured notes at 4.345% (five-year term), achieving BBB rating and enhancing capital flexibility.
Integration of recent acquisitions and continued focus on high-quality care and efficiency are key priorities for the remainder of the year.
Financial highlights
Consolidated Q1 revenue rose 24.2% year-over-year to $465.2 million, with Home Healthcare revenue up 29.8% to $205.4 million and long-term care revenue up 23.2% to $243.5 million.
Excluding out-of-period items, Q1 NOI increased by $16.7 million or 38.3%, and adjusted EBITDA rose by $15.2 million or 52%.
Q1 AFFO improved by 65% to $32.7 million; AFFO per share was $0.276, up 56% year-over-year.
Payout ratio declined to 41% on a trailing 12-month basis.
Net earnings per basic share rose to $0.427, and monthly dividend increased by 5% to $0.0441 per share.
Outlook and guidance
Expect organic Home Healthcare growth to moderate but remain above long-term trends due to demographic demand and hospital pressures.
Two new long-term care homes scheduled to open in 2026, with a pipeline of 17 projects representing over 3,700 beds.
Focus for the next few quarters will be on integration of acquisitions, deleveraging, and continued investment in technology and efficiency gains.
Redevelopment funded through capital-efficient joint ventures, with ongoing portfolio upgrades and management fee growth.
Management highlights operating leverage from technology-enabled back office and expects further value creation.
- Financial growth, expanded care, and all proposals approved amid sector and integration challenges.EXE
AGM 202626 Apr 2026 - Strong 2025 growth, 5% dividend hike, and $570M CBI Home Health acquisition set for Q2 2026.EXE
Q4 20256 Apr 2026 - Adjusted EBITDA up 42.7% year-over-year, driven by home health care and managed services growth.EXE
Q1 202531 Mar 2026 - Q2 2024 delivered strong revenue, margin growth, and robust progress in redevelopment.EXE
Q2 20241 Feb 2026 - Double-digit revenue and margin growth, with enhanced liquidity and redevelopment progress.EXE
Q3 202414 Jan 2026 - Q4 2024 saw strong growth, margin gains, and a 5% dividend hike amid robust demand.EXE
Q4 20241 Dec 2025 - All proposals passed, with a 5% dividend hike and major growth and governance initiatives.EXE
AGM 202526 Nov 2025 - Q2 2025 delivered 15.4% EBITDA growth and expansion from major acquisitions and home health care.EXE
Q2 202523 Nov 2025 - $570M deal creates Canada’s largest home health care platform, driving growth and efficiency.EXE
M&A Announcement20 Nov 2025
Next Extendicare earnings date
Next Extendicare earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)